![](https://www.biopharmadive.com/imgproxy/hWwVfwr-16rZYFj6OtYbVI3VmU8PapG2qnWObTe9Gic/g:nowe:0:0/c:5938:3354/rs:fit:770:435/bG9jYWw6Ly8vZGl2ZWltYWdlL0dldHR5SW1hZ2VzLTIxNTc5OTY4OTAuanBn.webp)
Supreme Court overturns Chevron doctrine, limiting reach of federal agencies
Dive Brief: The U.S. Supreme Court overturned the Chevron doctrine on Friday in a decision that could dramatically limit federal
Read MoreJune 30, 2024
Dive Brief: The U.S. Supreme Court overturned the Chevron doctrine on Friday in a decision that could dramatically limit federal
Read MoreToday, a brief rundown of news from PTC Therapeutics, Esperion Therapeutics and Coherus Biosciences, as well as updates from Sanofi,
Read MoreDive Brief: The Food and Drug Administration has rejected a gene therapy developed by Rocket Pharmaceuticals for a rare type
Read MoreDive Brief: Advisers to the Centers for Disease Control and Prevention on Thursday unanimously recommended Merck & Co.’s recently approved
Read MoreDive Brief: 2seventy Bio is shrinking further, announcing Thursday the sale of a hemophilia A research program, along with associated
Read MoreDive Brief: Shares of Moderna, Pfizer and GSK fell as advisers to the Centers for Disease Control and Prevention discussed
Read MoreDive Brief: Novo Nordisk will end a Phase 3 clinical trial of a hypertension drug it bought for up to
Read MoreOzempic and GLP-1 drugs like it became household names due to their potent weight loss benefits, and are now proving
Read MoreDive Brief: Wave Life Sciences on Tuesday said it will meet with regulators to discuss what kind of evidence would
Read MoreDive Brief: Novo Nordisk will spend $4.1 billion to build a new U.S. factory in North Carolina, the latest multibillion-dollar
Read More